Kevin Ho, M.D., joins Geisinger
Research investigator will also treat kidney patients
FOR IMMEDIATE RELEASE:
DANVILLE, PA -- Nephrologist Kevin Ho, M.D. (right), has joined Geisinger as a research investigator in the Geisinger Kidney Health Research Institute and as a kidney disease specialist, treating patients at Geisinger Medical Center in Danville.
Dr. Ho studies kidney disease at a molecular level and is interested in combining patient medical histories with detailed genomic data — becoming available through the MyCode Community Health Initiative — to identify the particular molecular pathways affected in subgroups of kidney disease patients to better target individualized treatments to patients.
Dr. Ho said he was excited to join Geisinger, both to treat patients and to pursue his research interests.
“Geisinger is ideally suited for this research work given its well-developed focus on personalized medicine and translational science as illustrated by its commitment to bioinformatics and genomic medicine,” Dr. Ho said.
Dr. Ho joins Geisinger from the University of Pittsburgh School of Medicine, where he served as an associate professor of medicine in the school’s renal-electrolyte division and its Clinical and Translational Science Institute.
A native of Cleveland, Ohio, Dr. Ho received his undergraduate degree in biological sciences from Harvard University in 1982 and his doctor of medicine degree from Columbia University in New York in 1987.
“We are pleased to have Dr. Ho join our team here at the Geisinger nephrology department and believe his experience in the care of patients with kidney disease will be a significant asset to our patients,” said Evan R. Norfolk, M.D., director of the nephrology department.
DANVILLE, PA -- Nephrologist Kevin Ho, M.D. (right), has joined Geisinger as a research investigator in the Geisinger Kidney Health Research Institute and as a kidney disease specialist, treating patients at Geisinger Medical Center in Danville.
Dr. Ho studies kidney disease at a molecular level and is interested in combining patient medical histories with detailed genomic data — becoming available through the MyCode Community Health Initiative — to identify the particular molecular pathways affected in subgroups of kidney disease patients to better target individualized treatments to patients.
Dr. Ho said he was excited to join Geisinger, both to treat patients and to pursue his research interests.
“Geisinger is ideally suited for this research work given its well-developed focus on personalized medicine and translational science as illustrated by its commitment to bioinformatics and genomic medicine,” Dr. Ho said.
Dr. Ho joins Geisinger from the University of Pittsburgh School of Medicine, where he served as an associate professor of medicine in the school’s renal-electrolyte division and its Clinical and Translational Science Institute.
A native of Cleveland, Ohio, Dr. Ho received his undergraduate degree in biological sciences from Harvard University in 1982 and his doctor of medicine degree from Columbia University in New York in 1987.
“We are pleased to have Dr. Ho join our team here at the Geisinger nephrology department and believe his experience in the care of patients with kidney disease will be a significant asset to our patients,” said Evan R. Norfolk, M.D., director of the nephrology department.
About Geisinger
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a research institute and the Geisinger College of Health Sciences, which includes schools of medicine, nursing and graduate education. With more than 25,000 employees and 1,700+ employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn and Twitter.